Key result
Cardiac Depression Scale demonstrates strong concurrent validity with the BDI-2 in CHD patients.
Why the study?
What are the psychometric properties of the Cardiac Depression Scale in patients with coronary heart disease?
Population
152 patients diagnosed with coronary heart disease, assessed 3.5 months after cardiac hospitalization.
Design
Cross-sectional
Follow-up
3.5 months after cardiac hospitalization
Authors
Loading...
Supports CDS validity in post-hospitalization CHD; extends original validation but leaves open routine clinical adoption.
Cross-Sectional (n=152)
Yes
What are the psychometric properties of the Cardiac Depression Scale in patients with coronary heart disease?
Effect estimate: r = 0.65
p-value: p=<0.001
The Cardiac Depression Scale is a valid and reliable tool for measuring depressive symptoms in patients with coronary heart disease.
Kiropoulos et al. (2012) conducted a cross-sectional in Coronary heart disease (n=152). Cardiac Depression Scale (CDS) vs. Beck Depression Inventory-2 (BDI-2) was evaluated on Concurrent validity with BDI-2 (r = 0.65, p=<0.001). The Cardiac Depression Scale demonstrated a six-factor structure, good internal consistency, and strong concurrent validity with the Beck Depression Inventory-2 (r = 0.65) in patients with coronary heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: